Rein Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $4.6M | $48.5M | $3.6M |
| FY2022 | $3.4M | $22.0M | $5.2M |
| FY2023 | $7.7M | $106.0M | $17.3M |
| FY2024 | $7.8M | $62.2M | $12.9M |
| FY2025 | $7.2M | $24.2M | $3.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $4.6M | $48.5M | $3.6M |
| FY2022 | $3.4M | $22.0M | $5.2M |
| FY2023 | $7.7M | $106.0M | $17.3M |
| FY2024 | $7.8M | $62.2M | $12.9M |
| FY2025 | $7.2M | $24.2M | $3.2M |